from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1216c/-

LFCtreatmentdescriptionclass of inhibitor

-0.740

Amikacinug/mL Amikacintranslation

-1.373

Cap5-10ug/mL Capreomycintranslation

-1.431

Rox10-50 ug/mL Roxithromycintranslation

-0.779

SM2-5 ug/mL Streptomycintranslation

0.558

Tet5-10 ug/mL Tetracyclinetranslation

0.073

Rif0.2-5ug/mL Rifampicintranscription

0.217

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.674

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.341

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.926

CPZ10-50 ug/mL Chlorpromazinerespiration

0.495

Clofazimine10-13 ug/mL Clofaziminerespiration

0.114

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.345

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.548

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.044

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.143

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.424

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.435

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.538

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.008

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.063

KCN5-20 ug/mL Potassium cyaniderespiration

-0.137

NaN30.2-2 mM Sodium aziderespiration

4.560

Nigericin50 uM Nigericinrespiration

0.161

TRC10-150 ug/mL Triclosanrespiration

0.807

TRZ10-25 ug/mL Thioridazinerespiration

-0.400

Valinomycin0.5-10 uM Valinomycinrespiration

0.004

ZnSO42 mM ZnSO4respiration

-0.010

menadione6-10 ug/mL Menadionerespiration

0.440

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.147

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.128

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.123

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.604

NRP_1Non-replicating persistence stage 1dosRassociated

-0.629

Amp0.2mg/mL AmpicillincellWall

-0.550

Cephalexin20-100 ug/mL CephalexincellWall

-0.566

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.037

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.736

EMB10-20 ug/mL EthambutolcellWall

-0.943

Eta12-40 ug/mL EthionamidecellWall

-0.743

INH0.2-0.4 ug/mL IsoniazidcellWall

1.492

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.540

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.724

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.172

BZA0.12 mg/mL BenzamidearomaticAmides

-0.492

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.665

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.316

H2O24 mM hydrogen peroxideDNAdamaging

-0.267

Levo10 ug/mL LevofloxacinDNAdamaging

0.049

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.088

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.026

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.255

UVUV-irradiationDNAdamaging

-0.081

ARP41-4 ug/mL Antitubercular compound ARP4?

0.298

Antimycin12.5-50 ug/mL Antimycin A?

-0.232

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.128

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.061

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.069

PA8240.2-2 ug/mL PA-824?

-0.525

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.015

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.505

Verapamil50 uM Verapamil?

-0.060

mercaptoethanol2 mM 2-Mercaptoethanol?

0.057

methoxatin10-20 ug/mL Methoxatin?